Cancer Chemotherapy and Pharmacology View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1978

PUBLISHER

Springer Berlin Heidelberg

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/280

Recent publications latest 20 shown

  • 2019-04-12 Neoadjuvant chemotherapy in patients with advanced endometrial cancer.
  • 2019-04-12 Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?
  • 2019-04-11 Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents.
  • 2019-04-11 Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.
  • 2019-04-10 Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique.
  • 2019-04-09 Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.
  • 2019-04-09 Comparison of two different carboplatin and weekly paclitaxel schedule in elderly advanced non-small cell lung cancer patients.
  • 2019-04-09 Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
  • 2019-04-09 Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
  • 2019-04-08 De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
  • 2019-04-08 Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
  • 2019-04-06 Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
  • 2019-04-04 An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.
  • 2019-04 d-dimer increase: an unfavorable factor for patients with primary liver cancer treated with TACE
  • 2019-04 Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma
  • 2019-04 Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade
  • 2019-04 Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody–cytotoxic drug conjugate
  • 2019-04 Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia
  • 2019-04 Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
  • 2019-04 Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B21007", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacology/Toxicology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B11001", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cancer Research", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.899", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.147", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "2.808", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.737", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.737", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.824", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.824", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.769", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.769", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.571", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.571", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "2.759", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "2.759", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.654", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.795", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.795", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "2.833", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "2.833", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.654", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "2.740", 
            "type": "Rating"
          }
        ], 
        "description": "

    Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

    The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

    ", "editor": [ { "familyName": "Sausville", "givenName": "Edward A.", "type": "Person" } ], "id": "sg:journal.1088364", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0344-5704", "1432-0843" ], "license": "Hybrid (Open Choice)", "name": "Cancer Chemotherapy and Pharmacology", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "29097" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0344-5704/CANCER CHEMOTHERAPY AND PHARMACOLOGY" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7806519" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "340159" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "280" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 80001635" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "88364" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14707" ] } ], "publisher": { "name": "Springer Berlin Heidelberg", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "1978", "type": "Periodical", "url": "http://link.springer.com/journal/280" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1088364'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1088364'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1088364'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1088364'


     

    This table displays all metadata directly associated to this object as RDF triples.

    210 TRIPLES      21 PREDICATES      51 URIs      44 LITERALS      31 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1088364 schema:about sg:ontologies/product-market-codes/B11001
    2 sg:ontologies/product-market-codes/B21007
    3 sg:ontologies/product-market-codes/H33160
    4 schema:contentRating N1a061970a14f4ca89bb80264344fad57
    5 N1bfb71e9a6c2497884111c7d7de87ea8
    6 N2b1eda3b828040119927e6f6a2f705a3
    7 N309c415ec22840b89753d8eee5062f18
    8 N32b9f27e43e043aca7877f2d2e2dc377
    9 N38b4990c44bf40cd87aad75ba6c47e6d
    10 N45d2cfe9842f4b9ca6fa7966ba5735b3
    11 N4a5c586040ee435b91d6427f11954801
    12 N5168916585c641cd8c2401882f23739d
    13 N5902f7020df1480ba174ad20828aa660
    14 N634baa7507fc4082b33e0fcbf9966260
    15 N75bc4f366fd846e7a864968d3efd9579
    16 N78079334e3a64646a9a692984096ec46
    17 N7e9362e0f8254dec862ecfc7ac795d69
    18 Na816a5f2f7a840619056c669a1198594
    19 Nb317a88d02124c2ab91f18bd01c0e940
    20 Nb8096c0c5e164bcf9ab9ba427bcd48ca
    21 Nce210d1a6aae4413bc044183d2a7a172
    22 Nd4b3ad0dafb349789481cff85404252f
    23 Nddbe82e859bf4ccaaa0079b4b06dcad6
    24 schema:description <p>Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. </p><p>The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.</p>
    25 schema:editor N1b6e60c184ea4680880e2935e48c4902
    26 schema:inLanguage en
    27 schema:isAccessibleForFree false
    28 schema:issn 0344-5704
    29 1432-0843
    30 schema:license Hybrid (Open Choice)
    31 schema:name Cancer Chemotherapy and Pharmacology
    32 schema:productId N18f5a84ef3774f1e9d22b29d4e30d34c
    33 N379d7bcc649242b8abc773c4a97e3a32
    34 N3a8ece69e8c34e178115c1d407f2ffc8
    35 N81261201789a468c970e4d3cf95d5c7d
    36 N940e4e6ae34340f6a4039e7d3ba121f9
    37 Nb034b619aa924b588e1a9a45551b7db4
    38 Ndc0d23f3f38040a8921b636ec45a9669
    39 Nfd08c6f9449b4755acdb9d0f2027bc18
    40 schema:publisher N0557b946427d4112acd9194c354a5178
    41 schema:publisherImprint Springer
    42 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364
    43 schema:sdDatePublished 2019-03-18T11:05
    44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    45 schema:sdPublisher N39e468089075464cb01e8b0b8312a42e
    46 schema:startYear 1978
    47 schema:url http://link.springer.com/journal/280
    48 sgo:license sg:explorer/license/
    49 sgo:sdDataset journals
    50 rdf:type schema:Periodical
    51 N0557b946427d4112acd9194c354a5178 schema:name Springer Berlin Heidelberg
    52 rdf:type schema:Organization
    53 N15655d420c164cecb4bcef5550c44110 rdf:first impact_factor_wos
    54 rdf:rest rdf:nil
    55 N18f5a84ef3774f1e9d22b29d4e30d34c schema:name nlm_unique_id
    56 schema:value 7806519
    57 rdf:type schema:PropertyValue
    58 N1a061970a14f4ca89bb80264344fad57 schema:author N8c48bc48d20e4472994500e4e4f718bd
    59 schema:dateCreated 2008
    60 schema:ratingValue 2.740
    61 rdf:type schema:Rating
    62 N1b6e60c184ea4680880e2935e48c4902 rdf:first Ncfdc9c8a8eed491c87d3cdcbfe07c3bd
    63 rdf:rest rdf:nil
    64 N1bfb71e9a6c2497884111c7d7de87ea8 schema:author N229c188dc6e84217800bd4b4c5a67faf
    65 schema:dateCreated 2012
    66 schema:ratingValue 2.795
    67 rdf:type schema:Rating
    68 N1c69c762565f4542a4dddd2ff7d54c9a rdf:first impact_factor_wos
    69 rdf:rest rdf:nil
    70 N229c188dc6e84217800bd4b4c5a67faf rdf:first impact_factor_wos
    71 rdf:rest rdf:nil
    72 N2b1eda3b828040119927e6f6a2f705a3 schema:author N15655d420c164cecb4bcef5550c44110
    73 schema:dateCreated 2010
    74 schema:ratingValue 2.759
    75 rdf:type schema:Rating
    76 N309c415ec22840b89753d8eee5062f18 schema:author Nd5cbc4cf715949eba3ec2fa3d571cd88
    77 schema:dateCreated 2013
    78 schema:ratingValue 2.571
    79 rdf:type schema:Rating
    80 N32b9f27e43e043aca7877f2d2e2dc377 schema:author N7c3b98d05b8c4731afe1cd7bfa1a57ea
    81 schema:dateCreated 2009
    82 schema:ratingValue 2.654
    83 rdf:type schema:Rating
    84 N379d7bcc649242b8abc773c4a97e3a32 schema:name scopus_id
    85 schema:value 29097
    86 rdf:type schema:PropertyValue
    87 N38b4990c44bf40cd87aad75ba6c47e6d schema:author N9aa8f9d1b16941aab8d2686e24cf5e17
    88 schema:dateCreated 2016
    89 schema:ratingValue 2.737
    90 rdf:type schema:Rating
    91 N39e468089075464cb01e8b0b8312a42e schema:name Springer Nature - SN SciGraph project
    92 rdf:type schema:Organization
    93 N3a8ece69e8c34e178115c1d407f2ffc8 schema:name springer_id
    94 schema:value 280
    95 rdf:type schema:PropertyValue
    96 N45d2cfe9842f4b9ca6fa7966ba5735b3 schema:author N95ed60fe49984fdfa17ebcc3e29e9b48
    97 schema:dateCreated 2009
    98 schema:ratingValue 2.654
    99 rdf:type schema:Rating
    100 N4a5c586040ee435b91d6427f11954801 schema:author Ncb7308afe61a40b4a0e99220feedf147
    101 schema:dateCreated 2012
    102 schema:ratingValue 2.795
    103 rdf:type schema:Rating
    104 N5168916585c641cd8c2401882f23739d schema:author Nd2d7e222a4144cf398162f2a6ad640fb
    105 schema:dateCreated 2014
    106 schema:ratingValue 2.769
    107 rdf:type schema:Rating
    108 N5627aced410446e8964829b679b0f484 rdf:first impact_factor_wos
    109 rdf:rest rdf:nil
    110 N5902f7020df1480ba174ad20828aa660 schema:author N7181290e12814e2da7fb91e6b7eec801
    111 schema:dateCreated 2015
    112 schema:ratingValue 2.824
    113 rdf:type schema:Rating
    114 N634baa7507fc4082b33e0fcbf9966260 schema:author N5627aced410446e8964829b679b0f484
    115 schema:dateCreated 2014
    116 schema:ratingValue 2.769
    117 rdf:type schema:Rating
    118 N7181290e12814e2da7fb91e6b7eec801 rdf:first impact_factor_wos
    119 rdf:rest rdf:nil
    120 N75bc4f366fd846e7a864968d3efd9579 schema:author Nf9ababbbbc514337969f8d0d7ca27ef1
    121 schema:dateCreated 2016
    122 schema:ratingValue 2.737
    123 rdf:type schema:Rating
    124 N78079334e3a64646a9a692984096ec46 schema:author Ne0afe216fb544c50a010d4eb36884f8f
    125 schema:dateCreated 2010
    126 schema:ratingValue 2.759
    127 rdf:type schema:Rating
    128 N7c3b98d05b8c4731afe1cd7bfa1a57ea rdf:first impact_factor_wos
    129 rdf:rest rdf:nil
    130 N7c68f913733446c78dc8771a73fbea9d rdf:first impact_factor_wos
    131 rdf:rest rdf:nil
    132 N7e9362e0f8254dec862ecfc7ac795d69 schema:author N1c69c762565f4542a4dddd2ff7d54c9a
    133 schema:dateCreated 2011
    134 schema:ratingValue 2.833
    135 rdf:type schema:Rating
    136 N81261201789a468c970e4d3cf95d5c7d schema:name dimensions_id
    137 schema:value 88364
    138 rdf:type schema:PropertyValue
    139 N8c48bc48d20e4472994500e4e4f718bd rdf:first impact_factor_wos
    140 rdf:rest rdf:nil
    141 N90cad6a980c442d096dbd31b4df012a3 rdf:first impact_factor_wos
    142 rdf:rest rdf:nil
    143 N940e4e6ae34340f6a4039e7d3ba121f9 schema:name wos_id
    144 schema:value 0344-5704/CANCER CHEMOTHERAPY AND PHARMACOLOGY
    145 rdf:type schema:PropertyValue
    146 N95ed60fe49984fdfa17ebcc3e29e9b48 rdf:first impact_factor_wos
    147 rdf:rest rdf:nil
    148 N9aa8f9d1b16941aab8d2686e24cf5e17 rdf:first impact_factor_wos
    149 rdf:rest rdf:nil
    150 Na816a5f2f7a840619056c669a1198594 schema:author Nc989aaba5ee143cbabf6b8c4e74e1573
    151 schema:dateCreated 2011
    152 schema:ratingValue 2.833
    153 rdf:type schema:Rating
    154 Nb034b619aa924b588e1a9a45551b7db4 schema:name lccn_id
    155 schema:value sn 80001635
    156 rdf:type schema:PropertyValue
    157 Nb317a88d02124c2ab91f18bd01c0e940 schema:author Nd2847cf78920419d87e2ab4e93a791f0
    158 schema:ratingValue 1.147
    159 rdf:type schema:Rating
    160 Nb8096c0c5e164bcf9ab9ba427bcd48ca schema:author N7c68f913733446c78dc8771a73fbea9d
    161 schema:dateCreated 2015
    162 schema:ratingValue 2.824
    163 rdf:type schema:Rating
    164 Nc989aaba5ee143cbabf6b8c4e74e1573 rdf:first impact_factor_wos
    165 rdf:rest rdf:nil
    166 Ncb7308afe61a40b4a0e99220feedf147 rdf:first impact_factor_wos
    167 rdf:rest rdf:nil
    168 Nce210d1a6aae4413bc044183d2a7a172 schema:author Ndb786fdb0ae044d99c1d1fd8bbc239a4
    169 schema:ratingValue 0.899
    170 rdf:type schema:Rating
    171 Ncfdc9c8a8eed491c87d3cdcbfe07c3bd schema:familyName Sausville
    172 schema:givenName Edward A.
    173 rdf:type schema:Person
    174 Nd2847cf78920419d87e2ab4e93a791f0 rdf:first sjr
    175 rdf:rest rdf:nil
    176 Nd2d7e222a4144cf398162f2a6ad640fb rdf:first impact_factor_wos
    177 rdf:rest rdf:nil
    178 Nd4b3ad0dafb349789481cff85404252f schema:author Nd6b1c37636da484fafab480e5573a016
    179 schema:dateCreated 2013
    180 schema:ratingValue 2.571
    181 rdf:type schema:Rating
    182 Nd5cbc4cf715949eba3ec2fa3d571cd88 rdf:first impact_factor_wos
    183 rdf:rest rdf:nil
    184 Nd6b1c37636da484fafab480e5573a016 rdf:first impact_factor_wos
    185 rdf:rest rdf:nil
    186 Ndb786fdb0ae044d99c1d1fd8bbc239a4 rdf:first snip
    187 rdf:rest rdf:nil
    188 Ndc0d23f3f38040a8921b636ec45a9669 schema:name era_ids_id
    189 schema:value 14707
    190 rdf:type schema:PropertyValue
    191 Nddbe82e859bf4ccaaa0079b4b06dcad6 schema:author N90cad6a980c442d096dbd31b4df012a3
    192 schema:dateCreated 2017
    193 schema:ratingValue 2.808
    194 rdf:type schema:Rating
    195 Ne0afe216fb544c50a010d4eb36884f8f rdf:first impact_factor_wos
    196 rdf:rest rdf:nil
    197 Nf9ababbbbc514337969f8d0d7ca27ef1 rdf:first impact_factor_wos
    198 rdf:rest rdf:nil
    199 Nfd08c6f9449b4755acdb9d0f2027bc18 schema:name nsd_ids_id
    200 schema:value 340159
    201 rdf:type schema:PropertyValue
    202 sg:ontologies/product-market-codes/B11001 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    203 schema:name Cancer Research
    204 rdf:type schema:DefinedTerm
    205 sg:ontologies/product-market-codes/B21007 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    206 schema:name Pharmacology/Toxicology
    207 rdf:type schema:DefinedTerm
    208 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    209 schema:name Oncology
    210 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...